98%
921
2 minutes
20
Objective: This study aimed to analyze cancer incidence and mortality patterns based on population-based cancer registry data for a defined region in Punjab, India, covering the period from January 2012 to December 2016.
Materials And Methods: Active hospital and laboratory surveillance and community health worker monitoring identified cases, which were validated using CanReg5 for accuracy. We determined age-adjusted incidence rates (AARs) together with crude rates (CRs) and mortality-to-incidence ratios (M/I %).
Results: A total of 11,471 new cancer cases were recorded, comprising 5,394 (47.0%) men and 6,077 (53.0%) women. The AARs were 108.2 per 100,000 in men and 124.6 per 100,000 in women. The overall CR was 92.7 per 100,000, and the M/I % was 26.9%. The most common cancer sites were the esophagus (987; 18.3%) in men and breast (1,489; 24.5%) in women. Rural residents had higher M/I % (28.5%) than urban residents (24.3%; p = 0.003), indicating later-stage diagnosis and care barriers. The Indian registries recorded the highest incidence of childhood lymphoma among girls.
Conclusion: The findings demonstrate the immediate requirement for specific awareness programs and early detection initiatives that should focus on rural regions to decrease Punjab's cancer statistics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320960 | PMC |
http://dx.doi.org/10.7759/cureus.87339 | DOI Listing |
Public Health
September 2025
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Objectives: Participation rates in fecal immunochemical test (FIT)-based colorectal cancer (CRC) screening differ across socio-demographic subgroups. The largest health gains could be achieved in subgroups with low participation rates and high risk of CRC. We investigated the CRC risk within different socio-demographic subgroups with low participation in the Dutch CRC screening program.
View Article and Find Full Text PDFTurk J Pediatr
September 2025
Department of Pediatric Hematology and Oncology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Background: The expression and clinical correlation of BRAFV600E mutation and programmed cell death-1 ligand 1 (PD-L1) in children with Langerhans cell histiocytosis (LCH) have been reported, but the conclusions of previous studies are inconsistent. In addition, it has been reported that elevated cathepsin S (CTSS) expression is associated with various cancers. However, there is currently no research on the correlation between CTSS and LCH.
View Article and Find Full Text PDFPurpose: In Armenia, a lower-middle-income country, cancer causes 21% of all deaths, with over half of cases diagnosed at advanced stages. Without universal health insurance, patients rely on out-of-pocket payments or black-market channels for costly immunotherapies, underscoring the need for real-world data to inform equitable policy reforms.
Methods: We conducted a multicenter, retrospective cohort study of patients who received at least one dose of an immune checkpoint inhibitor (ICI) between January 2017 and December 2023 across six Armenian oncology centers.
JCO Glob Oncol
May 2025
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Purpose: Breast cancer remains a significant public health challenge globally, as well as in India, where it is the most frequently diagnosed cancer in females. Significant disparities in incidence, mortality, and access to health care across India's sociodemographically diverse population highlight the need for increased awareness, policy reform, and research.
Design: This review consolidates data from national cancer registries, global cancer databases, and institutional findings from a tertiary care center to examine the epidemiology, clinical challenges, and management gaps specific to India.
JCO Glob Oncol
May 2025
Grupo Oncoclínicas, São Paulo, Brazil.
Head and neck squamous cell carcinoma (HNSCC) represents a significant public health burden in developing countries, where access to early diagnosis, comprehensive care, and research infrastructure is limited. This article synthesizes the insights generated during a Fireside Chat convened by members of the Latin American Cooperative Oncology Group (LACOG)-Head and Neck and the Brazilian Group of Head and Neck Cancer (GBCP), with the participation of international expert Professor Hisham Mehanna. The discussion addressed key challenges and opportunities in clinical and translational research within resource-constrained settings.
View Article and Find Full Text PDF